4.1
Q1: What are the main molecular targets that drugs bind to in the body?
Drugs typically bind to macromolecular targets including receptors, ion channels, transporters, and enzymes to modify their function. This binding initiates a cascade of molecular reactions that generate second messengers, which interact with downstream effectors to produce cellular responses. The specificity of drug-target interactions is crucial for therapeutic effectiveness.
Q2: How do agonist drugs differ from antagonist drugs in their mechanism of action?
Agonists mimic endogenous ligands and bind to targets to activate them, producing a cellular response. Antagonists compete with endogenous ligands for the same binding site and inhibit the biological response by blocking target activation. For example, isoprenaline acts as an agonist to increase heart rate, while atropine acts as an antagonist to slow it.
Q3: What is pharmacodynamics and why is it important in drug therapy?
Pharmacodynamics describes how drugs act on the body to produce physiological effects at specific sites. Understanding drug-target interactions, molecular cascades, and cellular responses is essential for predicting therapeutic outcomes and minimizing side effects. This knowledge helps optimize drug selection and dosing for effective treatment.
Q4: How do allosteric drugs differ from drugs that bind to the primary ligand binding site?
Allosteric drugs bind to alternative sites on targets rather than competing for the primary ligand binding site. These allosteric modulators can either enhance agonist binding or block it, offering a different mechanism of action. This selectivity can reduce off-target effects and improve therapeutic specificity compared to competitive inhibitors.
Q5: Why is drug specificity important, and what happens when it decreases at higher doses?
Drug specificity ensures that medications bind selectively to their intended targets, minimizing unwanted effects. As drug concentration increases, the compound can bind to unintended targets, causing side effects such as inflammation or tissue necrosis. Enhancing drug potency allows therapeutic effectiveness at lower doses with minimal off-target binding and adverse reactions.
Q6: What are examples of selective drug action in treating specific diseases?
Chloroquine, an antimalarial drug, selectively accumulates inside malarial parasites and kills them without harming host cells. Similarly, genetically modified oncolytic herpes viruses target melanoma tumors post-surgery. These examples demonstrate how drugs can be designed to selectively target pathogens or cancer cells while minimizing damage to healthy tissue.
Q7: How do physical and chemical properties of drugs influence their therapeutic activity?
Drug properties determine how effectively they interact with targets and produce desired effects. For example, antacids contain alkaline salts of calcium, magnesium, and aluminum that neutralize gastric acid, reducing corrosive effects on the esophagus. Similarly, biologics like monoclonal antibodies and genetically engineered enzymes leverage their chemical structure for specific therapeutic targeting.